BridgeMD
New treatment option for Cardiac Disease
Official title One-year Patency Comparison Between Radial Artery and No-touch Saphenous Vein Grafts in Women Undergoing Isolated CABG
ClinicalTrials.gov ID: NCT06179329
What this study is testing
- What it's testing
- The use of a graft from the left internal thoracic artery to the left anterior descending artery has become the gold standard for the indication of coronary artery bypass grafting. However, choosing a graft for the second-best coronary artery, focusing on long-term patency, is still a challenge.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75, women only
You may be able to join if
- Women aged 18 years or older and younger than 75 years, undergoing isolated and primary myocardial revascularization surgery, with triarterial...
You likely can't join if
- Preoperative conditions:
- Lack of the patient's written informed consent.
- Presence of poorly controlled diabetes, with a glycated hemoglobin value \>8 mg/dl.
- Emergency or salvage surgery, where the intervention needs to be performed quickly due to the critical clinical condition of the patient.
- Renal failure with glomerular filtration rate (creatinine clearance) \<30 mL/min.
- Inability to use the saphenous and/or radial vein
See the full eligibility criteria
- Women aged 18 years or older and younger than 75 years, undergoing isolated and primary myocardial revascularization surgery, with triarterial coronary artery disease (three vessels involved) in vessels subject to...
- Preoperative conditions:
- Lack of the patient's written informed consent.
- Presence of poorly controlled diabetes, with a glycated hemoglobin value \>8 mg/dl.
- Emergency or salvage surgery, where the intervention needs to be performed quickly due to the critical clinical condition of the patient.
- Renal failure with glomerular filtration rate (creatinine clearance) \<30 mL/min.
- Inability to use the saphenous and/or radial vein
- Positive Allen test using a pulse oximeter
- Presence of abnormal flow detected by means of a Doppler exam in one of the grafts to be used.
- History of vasculitis or Raynaud's syndrome, varicose veins, or history of previous saphenous vein removal
- Conditions that may affect patient follow-up
- Presence of advanced peripheral arterial disease
- Known contrast allergy: Presence of a documented allergy to the contrast agent used in radiological procedures.
- Impossibility of tracking due to geographic inaccessibility.
- Patients with lack of adherence to guidelines and/or prescribed medications.
The study team makes the final eligibility decision.
Where it's taking place
- São Paulo, São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include São Paulo, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.